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A B S T R A C T  
Background: Thyroid nodules are very common and its prevalence is largely dependent on the identification 
techniques. Recently high-resolution ultrasound thyroid imaging has paved the way for significant transformation in 
clinical approach to thyroid nodule. This study aimed to determine the efficacy of TI-RADS classification and its 
association with FNAC findings in thyroid lesions. 
Material and Methods: This prospective study was carried out in the Department of Radiology of Islamabad 
Diagnostic Centre, Islamabad for a period of 6 months from 6
th
 January 2018 to 6
th
 July, 2018. All male and female 
patients presenting with thyroid nodules were selected for the study. Ultrasound neck was performed with high 
frequency linear probes. Ultrasonography findings were classified according to Thyroid Imaging Reporting and Data 
System (TI-RADS) classification, as defined by Horvath et al. Patients with TI-RADS II-V were scheduled for US-guided 
Fine Needle Aspiration (FNA). All the specimens were sent to pathology laboratory for cytology (FNAC). 
Results: Total 123 patients of thyroid nodules were studied. Mean age of the patients was 45.78 ± 13.11 years, with a 
female predominance (73.2%). A significant association was seen between TI-RADS classification of thyroid nodules 
and findings on cytology. Thyroid nodules with TI-RADS II, III and IVa classification showed benign cytological findings, 
while TI-RADS class V had a significant association with malignant findings on cytology (P=0.001). 
Conclusions: TI-RADS classification is a reliable modality in differentiating benign thyroid nodules from malignant ones 
and circumvent the need for FNAC in every case with a thyroid nodule. 
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I n t r o d u c t i o n  
 
The thyroid gland (an essential endocrine gland) is 
present anterior to the trachea at the base of 
neck.
1 
Overall, thyroid nodules are quite prevalent, 
and most of these nodules are benign. A thyroid 
nodule is the development of a lump (solid or fluid-
filled) in the substance of thyroid gland. 
Ultrasonographically, thyroid gland lesions are 
distinguishable from the surrounding normal 
thyroid parenchyma.
2
 In case of thyroid 
malignancies, treatment of thyroid nodules is 
becoming a debatable subject. About 2-6% of 
thyroid nodules are easily detected by palpation, 
ORIGINAL ARTICLE 
                   J Islamabad Med Dental Coll 2020 130 
19-68% are diagnosed with ultrasonography (USG), 
however 8-65% are discovered on autopsy.
3,4
 
Among those detected through palpation or the 
USG, the incidence of carcinoma is about 5-15%.
3,5
 
In a population-based research, the malignancy 
rate among  fine-needle aspiration (FNA) assessed 
non-palpable nodules was 8-12%, and among 
thyroid nodules detected through palpation was 
1.6% .
3,5,6  
Among endocrine glands, thyroid cancer is the 
most prevalent malignancy, accounting for 3.8% of 
all newly appearing cancer patients in the U.S and is 
the ninth most prevalent cancer, in general.
1 
The 
number of individuals diagnosed with thyroid 
malignancy has risen significantly over the last 30 
years.
2 
Thyroid FNAC is the primary thyroid nodule 
diagnostic test. Thyroid FNAC is graded into six 
groups by the Bethesda system and also predicts 
the risk of carcinoma.
7 
USG-guided FNA has an 
important contribution in managing thyroid 
nodules because of its accuracy and safety. 
However, even with USG guidance, sampling errors 
or non-representative sampling can occur during 
FNA.
8 
Still it is regarded as a cost-effective method 
of investigation for thyroid nodules.
9
 
Horvath et al proposed TI-RADS for 
ultrasonographic evaluation and classification of 
patients with thyroid nodule prior to FNAC/FNA 
biopsy to safeguard them from unwanted 
complications.
10,11 
Some studies found TI-RADS 
classification as a sensitive method for identifying 
patients with thyroid cancer,
12,13 
while others 
advocated the need of cancer prediction with more 
sensitive gold-standard technique of FNAB.
13 
This 
study was planned in the context of these 
controversies and unavailability of relevant data in 
local settings. The objective was to compare the 
effectiveness of TI-RADS classification with 
cytological confirmation in diagnosing thyroid 
nodules. 
 
M a t e r i a l  a n d  M e t h o d s  
This prospective study was performed at the 
Radiology Department of Islamabad Diagnostic 
Center, Islamabad Pakistan. The study duration was 
6 months from 6
th
 January 2018 to 6
th
 July 2018. 
Approval was obtained from ethics review 
committee of the hospital. Patients were informed 
about the possible complications of FNA procedure 
and outcome of the study and written, informed 
consent was taken from each one of them.  
Sample size was calculated by taking prevalence of 
thyroid nodules as 13%
14
, with 90% confidence 
level and 5% margin of error. Total of 123 patients 
of either gender, with thyroid nodules detected by 
ultrasound (GE Logiq P7), classified as TIRADS II-V 
and scheduled for FNAC, were included. Patients 
with normal scan of thyroid (TI-RADS class I), 
already known thyroid pathology and those who 
refused to be a part of the study, were excluded. 
Complete clinical examination and required 
laboratory investigation were done in all patients. 
All the patients underwent High-resolution B-mode 
ultrasound scan performed by an experienced 
radiologist, having more than 5 years of experience. 
TI-RADS proposed by Horvath et al. in 2009 was 
followed for classification of thyroid nodules 
because it has a fair inter-observer agreement. 
Following ultrasound (USG) evaluation of thyroid 
gland, USG-guided FNAC was carried out by the 
same radiologists who performed the USG. A 23-
gauge needle, linked to a 2ml disposable plastic 
syringe and aspirator, were used for FNAC. 
Aspiration of each lesion was done twice. All the 
specimens were sent to the pathology laboratory 
for cytology. The data was recorded on a proforma 
and analysis was done by using SPSS version 20. 
Chi-square test was applied and a P-value <0.05 
was considered as statistically significant. 
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R e s u l t s  
Total 123 patients with thyroid nodules were 
studied. Mean age of the patients was 45.78±13.11 
years and the most common age group was 25-40 
years (41.5%). Regarding gender predilection, there 
were more female patients (73.2%) with thyroid 
nodules than male patients (26.8%) (Table I). 
Table: I. Distribution of study patients according to 
age groups and gender (n=123) 
Variables  
Frequency 
n (%) 
Age groups (years) 
25-40  51 (41.5%) 
41-55  42 (34.1%) 
56-70  30 (24.4%) 
Total 123 
Gender 
Male  33 (26.8%) 
Female  90 (73.2%) 
Total 123 
 
Most of the thyroid nodules detected on USG were 
classified as TI-RADS class II (56.10%) (Figure 1). 
 
Figure 1: TI-RADS classification of thyroid nodules on 
USG(n=123) 
A significant association was seen between TI-RADS 
classification of thyroid nodules and findings on 
cytology. Thyroid nodules with TI-RADS II, III and 
IVa classification showed benign cytological 
findings, while TI-RADS class V had a significant 
association with malignant findings on cytology 
(P=0.001) (Table II). 
D i s c u s s i o n  
The prevalence of thyroid nodules is increasing 
worldwide. Currently, it is reported to be around 
19-67%, of which about 5-15% are usually 
malignant.
15 
In Pakistan, the percentage of 
malignancy is reported to be 11-14.35%.
14 
In this 
study, we found a significant association of the TI-
RAD class V with malignant thyroid nodules on 
FNAC, while TI-RADS II, III and IVa were significantly 
associated with benign thyroid nodules. 
 
Our results are comparable to that of Dy and 
colleagues.
13 
They carried out a retrospective study 
on 149 patients with thyroid nodules, with majority 
of them being female patients (87%). They 
compared TI-RAD classification with FNAB and 
concluded that higher TI-RAD class is associated 
with greater risk of malignancy. They also reported 
that TI-RADS classification varies between TI-RADS 
1 and 5. TI-RADS 1 is compatible with a typical 
thyroid gland, TI-RADS 2 with benign nodules, TI-
RADS 3 with possibly benign nodules, TI-RADS 4 
with USG characteristics suspicious of malignancy 
and TI-RADS 5, nodules highly indicative of 
malignancy.
13
 
Results of our study are also in line with the 
research by Zhuang et al.
15 
In their pursuit to 
develop a practical TI-RAD system, they also 
compared the TI-RADS findings with FNAB in 153 
patients. They found TI-RADS to be 97% accurate 
and the TI-RAD system they devised showed the 
risk of malignancy in different classes of TIRADS as 
follows; TIRADS 2(0% malignancy), TIRADS 3 (3.6% 
malignancy), TIRADS 4 (17-75% malignancy), and 
TIRADS 5 (98% malignancy).
15 
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Table II: Association of TI-RADS classification with cytology findings of thyroid nodules (n=123) 
TI-RAD classification 
Cytology findings 
Total 
P-value* 
Benign Malignant 
Suspected 
malignancy 
papillary 
carcinoma 
Cystic fluid 
II 64 0 2 0 3 69 
0.001 
III 19 1 2 0 0 22 
IVa 6 0 0 0 0 6 
IVb 0 1 1 0 0 2 
IVc 1 1 1 0 0 3 
V 12 3 3 3 0 21 
Total 102 6 9 3 3 123 
*P-value <0.05 was considered statistically significant 
 
Kwak et al.
16
 utilized a simpler and more practical 
TI-RADS scoring grounded on BI-RADS category like 
category 3 (without any suspected features of US), 
4a (one suspicious characteristic), 4b (2 suspicious 
characteristics), 4c (3/4 suspicious characteristics). 
This facilitated risk stratification of a malignant 
thyroid nodule.
16
 
Vargas-Uricoechea et al.
17 
tried to find concordance 
of TIRADS with Bethesda cytology criteria. The 
mean age of patients in their study was 57 years 
with a predominance of females (75%). They found 
the highest concordance between the two 
modalities in TIRADS class II. They inferred that 
TIRAD classification of benign nodules usually 
complements the cytology results therefore 
unnecessary intervention can be avoided in such 
patients.  
The main limitation of this study was a small 
sample size and including patients from a single 
institution, so the results of this study cannot be 
generalized to the entire population. Second 
employing FNAB instead of FNAC for comparison 
with TI-RADS categories would give more reliable 
results as biopsy is regarded as gold standard for 
diagnosis of benign and malignant lesions. 
 
 
 
C o n c l u s i o n  
There is a significant association between TI-RAD 
classification and cytological findings from FNAC of 
thyroid nodules. TI-RADS classification is a reliable 
diagnostic modality and can be used for detection 
of thyroid lesions independent of FNAC, thus 
reducing the burden of unnecessary biopsies. 
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